Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure<SUBTITLE>The EVEREST Clinical Status Trials</SUBTITLE>

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

JAMA

Topics

Medicine

Pathology

Internal Medicine

Cardiology

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.1001/jama.297.12.1332